Submitted:
06 July 2024
Posted:
08 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Material and Method
2.1. Study Area
2.2. Study Design and Data Collection
2.3. Sample Collection
2.4. Serological Investigation
2.5. DNA Extraction, RT-PCR, and Genotyping
2.6. Data Analysis
3. Results
3.1. Overall Prevalence of HBV
3.2. Gender Wise Prevalence
3.3. Prevalence of HBV in Different Age Groups Conformed Serologically
3.4. Prevalence of HBV in Different Age Groups Tested through RT-PCR.
3.5. Prevalence of HBV Enotypes
3.6. Risk Factors Based Analysis
| ICT Based Risk Factor | Total | No | Yes | % Age | P Value |
|---|---|---|---|---|---|
| Family member with Positive | 147 | 145 | 2 | 1.4 | .0001 |
| History of dental procedure | 147 | 62 | 85 | 57.8 | |
| History of surgery | 147 | 86 | 61 | 41.8 | |
| History of transfusion plasma or blood | 147 | 84 | 63 | 42.9 | |
| History of ear, nose, piercing, or tattooing, syringe | 147 | 64 | 83 | 56.5 | |
| Married | 147 | 52 | 95 | 64.6 | |
| History of Barbers Shop | 147 | 89 | 58 | 39.45 | |
| History of Injection Drugs use | 147 | 91 | 56 | 38.1 |

4. Discussion:
5. Conclusion
References
- Mieli-Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., . . . Montano-Loza, A. J. (2018). Autoimmune hepatitis. Nature Reviews Disease Primers, 4(1), 1-21.
- Raviglione, M. C., Snider, D. E., & Kochi, A. (1995). Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. Jama, 273(3), 220-226.
- Torre, P., Aglitti, A., Masarone, M., & Persico, M. (2021). Viral hepatitis: Milestones, unresolved issues, and future goals. World Journal of Gastroenterology, 27(28), 4603.
- Eke, A. C., Eke, U. A., Okafor, C. I., Ezebialu, I. U., & Ogbuagu, C. (2011). Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virology journal, 8(1), 1-8. [CrossRef]
- El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142(6), 1264-1273. e1261. [CrossRef]
- Nazeer, A., Ali, S., & Tipu, I. (2019). Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan. BioScientific Review, 1(4), 20-28. [CrossRef]
- Jindal, A., & Sarin, S. K. (2023). Hepatitis B:“Treat all” or “Treat select”. Hepatology International, 17(1), 38-41.
- Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H. (2023). Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nature reviews Gastroenterology & hepatology, 1-14. [CrossRef]
- Alberts, C. J., Clifford, G. M., Georges, D., Negro, F., Lesi, O. A., Hutin, Y. J., & de Martel, C. (2022). Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. The Lancet Gastroenterology & Hepatology. [CrossRef]
- Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet, 386(10003), 1546-1555. [CrossRef]
- Hwang, E. W., & Cheung, R. (2011). Global epidemiology of hepatitis B virus (HBV) infection. North American Journal of Medicine and Science, 4(1). [CrossRef]
- Anwar, F., Khan, M., Salman, M., Ahmad, S., Ullah, F., Khan, J., . . . Abbas, M. (2021). Seroprevalence of hepatitis B virus in human population of district Buner Khyber Pakhtunkhwa Pakistan. Clinical Epidemiology and Global Health, 10, 100688. [CrossRef]
- Shah, M. I., & Awan, Z. U. R. (2020). 30. Sero prevalence of Hepatitis B Virus (HBV) in general population of Lakki Marwat, Khyber Pakhtunkhwa-Pakistan. Pure and Applied Biology (PAB), 9(4), 2511-2520.
- Akoth, A. J. (2021). Prevalence and factors associated with hepatitis B and human immunodeficiency virus co-infection among blood donors in Kenyan Coastal Region. JKUAT-COHES.
- Butt, T., & Amin, M. (2008). Seroprevalence of hepatitis B and C infections among young adult males in Pakistan. EMHJ-Eastern Mediterranean Health Journal, 14 (4), 791-797, 2008.
- Zali, M. R. (1996). Epidemiology of hepatitis B in the Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal, 2 (2), 290-298, 1996. [CrossRef]
- Ali, A., Nisar, M., Idrees, M., Ahmad, H., Hussain, A., Rafique, S., . . . Wazir, S. (2012). Prevalence of HBV infection in suspected population of conflict-affected area of war against terrorism in North Waziristan FATA Pakistan. Infection, Genetics and Evolution, 12(8), 1865-1869. [CrossRef]
- Hauri, A. M., Armstrong, G. L., & Hutin, Y. J. (2004). The global burden of disease attributable to contaminated injections given in health care settings. International journal of STD & AIDS, 15(1), 7-16. [CrossRef]
- Khan, A., & Qazi, J. (2018). Risk factors and molecular epidemiology of HBV and HCV in internally displaced persons (IDPs) of North Waziristan Agency, Pakistan. JPMA J Pak Med Assoc, 68(2), 165-169.
- Ozaras, R., Balkan, I. I., Yemisen, M., & Tabak, F. (2015). Epidemiology of HBV subgenotypes D. Clinics and Research in Hepatology and Gastroenterology, 39(1), 28-37.
- Saleha, S., Kamal, A., Ullah, F., Khan, N., Mahmood, A., & Khan, S. (2014). Prevalence of hepatitis C virus genotypes in district Bannu, Khyber Pakhtunkhwa, Pakistan. Hepatitis Research and Treatment, 2014. [CrossRef]





| Diagnostic Tests | Total | N.of HBV+ | N. of HBV- |
|---|---|---|---|
| ICT ELISA RT-PCR |
943 147 109 |
147 109 56 |
796 38 53 |
| Diagnosis | Total ♂ | ♂ Positive | Total ♀ | ♀ Positive |
|---|---|---|---|---|
| ICT | 626 | 93 | 317 | 54 |
| ELISA | 626 | 70 | 317 | 39 |
| RT-PCR | 626 | 41 | 317 | 15 |
| Age groups | Total | ICT+ % Age |
ELISA+ % Age |
ICT | ELISA |
|---|---|---|---|---|---|
| I (1-15) | 73 | 6 8.2% |
2 2.7% |
p- value = 0.0001 |
p- value = 0.001 |
| II (16-30) | 305 | 60 19.7% |
52 17% |
||
| III (31-45) | 340 | 65 19.1% |
42 12.4% |
||
| IV (46-60) | 156 | 10 6.4% |
8 5.1% |
||
| IV (61-75) | 69 | 6 8.7% |
5 7.2% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).